Clinical data platforms require absolute precision in CDISC standards, EDC documentation, and SDTM mapping. Editorial errors in clinical study reports or regulatory submissions can trigger FDA queries and delay drug approvals.

Our assessments evaluate candidates' mastery of CDISC terminology, eCRF validation logic, and regulatory formatting. We identify professionals who maintain data integrity while navigating complex SDTM structures.

Illustrative scenario

SDTM Domain Mapping Error Triggers Six-Month FDA Review Delay

A clinical data manager incorrectly mapped adverse event severity codes between CDASH and SDTM domains in a Phase III oncology trial submission. The FDA issued a Complete Response Letter requiring full dataset revalidation, delaying drug approval by six months and costing $47 million in extended trial maintenance.

A composite example of a failure mode that is common in Clinical Data Platforms. It is not an account of a real client engagement and no real organisation is described.

Documents You'll Be Testing

Clinical Study Reports
Data Management Plans
SDTM Implementation Guides
Electronic Case Report Forms
Statistical Analysis Plans
Regulatory Submission Modules

Avoid These Common Editorial Mistakes

Incorrect SDTM domain mapping

FDA Complete Response Letters requiring dataset resubmission and approval delays

eCRF validation rule inconsistencies

Data integrity failures triggering regulatory inspection and patient safety concerns

Controlled terminology violations

Regulatory queries halting clinical trial progression and increasing operational costs

ADaM derivation logic errors

Statistical analysis invalidation requiring complete efficacy dataset regeneration

21 CFR Part 11 compliance gaps

Electronic records rejection by FDA requiring full audit trail reconstruction

Master These Key Terms

CDASH vs SDTM
Serious Adverse Event vs Severe Adverse Event
EDC vs eCRF
ADaM vs STDM
Controlled Terminology vs Preferred Terms

Smart Hiring Strategies

Prioritize candidates with CDISC CDASH and SDTM fluency who understand EDC validation requirements. Look for regulatory submission experience and knowledge of ICH-GCP guidelines.

Clinical data platforms operate under strict FDA oversight where terminology precision impacts patient safety and approval timelines. Editorial errors in CDISC documentation can halt trials and expose companies to significant liability.

Frequently Asked Questions

How technical should our clinical data platform candidates' writing skills be?
Candidates must demonstrate fluency with CDISC standards and regulatory terminology. They should write clear validation specifications, map CDASH to SDTM domains accurately, and format regulatory submissions according to FDA guidelines without compromising scientific precision.
What's the biggest language-related risk when hiring clinical data managers?
Terminology confusion between CDISC domains or misapplied controlled vocabulary can trigger regulatory queries. A single incorrectly documented adverse event or validation rule can halt clinical trials and cost millions in timeline delays.
Should we test candidates on both FDA and EMA documentation standards?
Yes, clinical data platforms serve global markets requiring dual compliance. Test candidates' ability to format CTD modules, apply ICH-GCP guidelines, and maintain consistent terminology across different regulatory frameworks for international submissions.
How do we evaluate candidates' understanding of 21 CFR Part 11 requirements?
Assess their ability to document electronic signature workflows, audit trail specifications, and data integrity controls. Candidates should demonstrate understanding of how editorial precision in system documentation impacts regulatory compliance validation.
What writing samples should we request from clinical data platform candidates?
Request SDTM implementation guides, data management plan excerpts, or clinical study report sections. These documents reveal candidates' mastery of CDISC terminology, regulatory formatting requirements, and ability to maintain data traceability documentation.